XT
ELTX icon

XTX Topco’s Elicio Therapeutics ELTX Stock Holding History

XTX Topco’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Buy
+13,785
New +$133K ﹤0.01% 2961
2022
Q1 		– Sell
-1,006
Closed -$29K – 739
2021
Q4 		$29K Buy
+1,006
New +$50.9K 0.02% 607

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Topco's ELTX Position: Q1 2026 in Review

XTX Topco opened a new position in Elicio Therapeutics (ELTX) in Q1 2026: 13,785 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #2961 among its holdings. This is a return to the name: XTX Topco previously reported a position in ELTX as recently as Q4 2021.

XTX Topco first reported a position in ELTX in Q4 2021 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

  • XTX Topco held 13,785 shares of Elicio Therapeutics worth $147K as of Q1 2026.
  • Elicio Therapeutics was a new XTX Topco position in Q1 2026.
  • Elicio Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2961 holding.
  • XTX Topco first reported a position in Elicio Therapeutics in Q4 2021 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.